Drug Price Transparency

Name: Drug Price Transparency
Creator: Newspaper Daily
License: United States government work; public domain unless the source record says otherwise.

Drug Price Transparency organizes records from CMS data API into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.

Records: 5,000
Last changed: 08/30/2026
Update schedule: 50 16 1 */3 * UTC
Coverage: 01/01/2024–01/01/2024
Method: Methodology

Record	Record Date	Vuga Group	Change Status	Recency Days	Public Significance Score
Bexarotene*	01/01/2024	Bexarotene	increased	972.23	100
Bexarotene*	01/01/2024	Bexarotene	increased	972.23	100
Bexsero	01/01/2024	Meningococcal B Vaccine,4-Comp	increased	972.23	100
Bexsero	01/01/2024	Meningococcal B Vaccine,4-Comp	increased	972.23	100
Bicillin L-A	01/01/2024	Penicillin G Benzathine	increased	972.23	100
Bicillin L-A	01/01/2024	Penicillin G Benzathine	increased	972.23	100
Biktarvy	01/01/2024	Bictegrav/Emtricit/Tenofov Ala	increased	972.23	100
Biktarvy	01/01/2024	Bictegrav/Emtricit/Tenofov Ala	increased	972.23	100
Bimzelx Autoinjector	01/01/2024	Bimekizumab-Bkzx	increased	972.23	100
Bimzelx Autoinjector	01/01/2024	Bimekizumab-Bkzx	increased	972.23	100
Bimzelx	01/01/2024	Bimekizumab-Bkzx	increased	972.23	100
Bimzelx	01/01/2024	Bimekizumab-Bkzx	increased	972.23	100
Blincyto	01/01/2024	Blinatumomab	increased	972.23	100
Blincyto	01/01/2024	Blinatumomab	increased	972.23	100
Boostrix Tdap	01/01/2024	Diphth,Pertuss(Acell),Tet Vac	increased	972.23	100
Boostrix Tdap	01/01/2024	Diphth,Pertuss(Acell),Tet Vac	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bortezomib*	01/01/2024	Bortezomib	increased	972.23	100
Bosulif	01/01/2024	Bosutinib	increased	972.23	100
Bosulif	01/01/2024	Bosutinib	increased	972.23	100
Bosulif	01/01/2024	Bosutinib	increased	972.23	100
Botox	01/01/2024	Onabotulinumtoxina	increased	972.23	100
Botox	01/01/2024	Onabotulinumtoxina	increased	972.23	100
Braftovi	01/01/2024	Encorafenib	increased	972.23	100
Braftovi	01/01/2024	Encorafenib	increased	972.23	100
Briumvi	01/01/2024	Ublituximab-Xiiy	increased	972.23	100
Briumvi	01/01/2024	Ublituximab-Xiiy	increased	972.23	100
Brixadi	01/01/2024	Buprenorphine	increased	972.23	100
Brixadi	01/01/2024	Buprenorphine	increased	972.23	100
Brukinsa	01/01/2024	Zanubrutinib	increased	972.23	100
Brukinsa	01/01/2024	Zanubrutinib	increased	972.23	100
Butrans	01/01/2024	Buprenorphine	increased	972.23	100
Butrans	01/01/2024	Buprenorphine	increased	972.23	100
Bydureon Bcise	01/01/2024	Exenatide Microspheres	increased	972.23	100
Bydureon Bcise	01/01/2024	Exenatide Microspheres	increased	972.23	100
Byetta	01/01/2024	Exenatide	increased	972.23	100
Byetta	01/01/2024	Exenatide	increased	972.23	100
Bylvay	01/01/2024	Odevixibat	increased	972.23	100
Bylvay	01/01/2024	Odevixibat	increased	972.23	100
Byooviz	01/01/2024	Ranibizumab-Nuna	increased	972.23	100
Byooviz	01/01/2024	Ranibizumab-Nuna	increased	972.23	100
Cabenuva	01/01/2024	Cabotegravir/Rilpivirine	increased	972.23	100